Palisade Bio (PALI) Other financing activities (2021 - 2026)
Palisade Bio (PALI) reported Other financing activities of $46000.0 for Q1 2026, down 74.16% year-over-year from $178000.0 in Q1 2025, and down 89.55% quarter-over-quarter from $440000.0 in Q4 2025.
Palisade Bio (PALI) Other financing activities (2021 - 2026) Analysis & Trends
Palisade Bio (PALI) has 6 years of Other financing activities data on file, last reported at $46000.0 in Q1 2026.
- Other financing activities for Q1 2026 came in at $46000.0, down 74.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.8 million (up 816.53% YoY), and the FY2025 annual result was $618000.0, up 7.29% from the prior year.
- Other financing activities fell to $46000.0 in Q1 2026 per PALI's latest filing, from $440000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $9.3 million in Q3 2025 and troughed at $46000.0 in Q1 2026.
- A 5-year average of $985285.7 and a median of $331000.0 in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2023 and 2025: Other financing activities slumped 82.99% in 2023, then soared 13620.59% in 2025.
- A 5-year view of Other financing activities shows it stood at $294000.0 in 2022, then tumbled by 82.99% to $50000.0 in 2023, then soared by 140.0% to $120000.0 in 2024, then jumped by 266.67% to $440000.0 in 2025, then tumbled by 89.55% to $46000.0 in 2026.
- Business Quant data shows PALI's Other financing activities at $46000.0 in Q1 2026, $440000.0 in Q4 2025, and $9.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Sep 30, 2025 | 9.33 Mn |
| Sep 30, 2025 | 9.33 Mn |
| Mar 31, 2025 | 178,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 345,000.00 |
| Sep 30, 2023 | 345,000.00 |
| Jun 30, 2023 | 854,000.00 |
| Jun 30, 2023 | 854,000.00 |